150 related articles for article (PubMed ID: 37027168)
41. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
[TBL] [Abstract][Full Text] [Related]
42. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
[TBL] [Abstract][Full Text] [Related]
43. Central nervous system lymphoma: patterns of incidence in Indian population and effect of steroids on stereotactic biopsy yield.
Manoj N; Arivazhagan A; Mahadevan A; Bhat DI; Arvinda HR; Devi BI; Sampath S; Chandramouli BA
Neurol India; 2014; 62(1):19-25. PubMed ID: 24608449
[TBL] [Abstract][Full Text] [Related]
44. Clinical features and diagnosis of primary central nervous system lymphoma.
Fitzsimmons A; Upchurch K; Batchelor T
Hematol Oncol Clin North Am; 2005 Aug; 19(4):689-703, vii. PubMed ID: 16083830
[TBL] [Abstract][Full Text] [Related]
45. Lymphomatosis cerebri: a rare variant of primary central nervous system lymphoma and MR imaging features.
Yu H; Gao B; Liu J; Yu YC; Shiroishi MS; Huang MM; Yang WX; Guan ZZ
Cancer Imaging; 2017 Oct; 17(1):26. PubMed ID: 28982392
[TBL] [Abstract][Full Text] [Related]
46. A comparative study of multimodal magnetic resonance in the differential diagnosis of acquired immune deficiency syndrome related primary central nervous system lymphoma and infection.
Li J; Xue M; Yan S; Guan C; Xie R; Chen B
BMC Infect Dis; 2021 Feb; 21(1):165. PubMed ID: 33568094
[TBL] [Abstract][Full Text] [Related]
47. Incidence and radiographic findings of primary central nervous system lymphoma in immunocompetent patients in southern Thailand.
Rujirojindakul P; Rohitoprakarn M; Kongkabpan D; Viboonjantra P; Lekhakula A
Tumori; 2008; 94(3):304-8. PubMed ID: 18705395
[TBL] [Abstract][Full Text] [Related]
48. Atypical radiological findings of primary central nervous system lymphoma.
Lin X; Khan IRA; Seet YHC; Lee HY; Yu WY
Neuroradiology; 2020 Jun; 62(6):669-676. PubMed ID: 32077984
[TBL] [Abstract][Full Text] [Related]
49. In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy.
Marcelis L; Antoranz A; Delsupehe AM; Biesemans P; Ferreiro JF; Debackere K; Vandenberghe P; Verhoef G; Gheysens O; Cattoretti G; Bosisio FM; Sagaert X; Dierickx D; Tousseyn T
Cancer Immunol Immunother; 2020 Sep; 69(9):1751-1766. PubMed ID: 32335702
[TBL] [Abstract][Full Text] [Related]
50. 18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma.
Kawai N; Miyake K; Yamamoto Y; Nishiyama Y; Tamiya T
Biomed Res Int; 2013; 2013():247152. PubMed ID: 23844359
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic delay in primary central nervous system lymphoma.
Haldorsen IS; Espeland A; Larsen JL; Mella O
Acta Oncol; 2005; 44(7):728-34. PubMed ID: 16227164
[TBL] [Abstract][Full Text] [Related]
52. Analysis of Key Factors Associated with Response to Salvage High-Dose Methotrexate Rechallenge in Primary Central Nervous System Lymphoma with First Relapse.
Du P; Chen H; Shen L; Liu X; Wu X; Chen L; Cao A; Geng D
Curr Oncol; 2022 Sep; 29(9):6642-6656. PubMed ID: 36135091
[TBL] [Abstract][Full Text] [Related]
53. Diagnosis and treatment of primary central nervous system lymphoma.
Gavrilovic IT; Abrey LE
Curr Oncol Rep; 2005 Jan; 7(1):47-54. PubMed ID: 15610686
[TBL] [Abstract][Full Text] [Related]
54. Primary central nervous system lymphoma.
Abrey LE
Curr Opin Neurol; 2009 Dec; 22(6):675-80. PubMed ID: 19741527
[TBL] [Abstract][Full Text] [Related]
55. Primary CNS lymphoma.
Touitou V; LeHoang P; Bodaghi B
Curr Opin Ophthalmol; 2015 Nov; 26(6):526-33. PubMed ID: 26367092
[TBL] [Abstract][Full Text] [Related]
56. The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients.
Wu S; Wang J; Liu W; Hu F; Zhao K; Jiang W; Lei T; Shu K
BMC Neurol; 2021 May; 21(1):190. PubMed ID: 33975554
[TBL] [Abstract][Full Text] [Related]
57. Ex vivo NMR metabolomics approach using cerebrospinal fluid for the diagnosis of primary CNS lymphoma: Correlation with MR imaging characteristics.
Kim JH; An YJ; Kim TM; Kim JE; Park S; Choi SH
Cancer Med; 2023 Feb; 12(4):4679-4689. PubMed ID: 35941814
[TBL] [Abstract][Full Text] [Related]
58. A case of primary central nervous system lymphoma presenting diffuse infiltrative leukoencephalopathy.
Yamamoto T; Kojima K; Koibuchi K; Ito S; Higuchi Y; Iwadate Y; Oide T; Kuwabara S
Intern Med; 2012; 51(9):1103-6. PubMed ID: 22576396
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
Li J; Tang X; Luo X; Liu L; Li D; Yang L
Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
[TBL] [Abstract][Full Text] [Related]
60. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H
Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
